awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35622444-59362E6F-DF15-45EB-832E-EE8706FCF4DA
Q35622444-59362E6F-DF15-45EB-832E-EE8706FCF4DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35622444-59362E6F-DF15-45EB-832E-EE8706FCF4DA
First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
P2860
Q35622444-59362E6F-DF15-45EB-832E-EE8706FCF4DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35622444-59362E6F-DF15-45EB-832E-EE8706FCF4DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36d1cae5b70375de0c8fcd1e19d19fe1779decdd
P2860
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.